Cargando…

Attitudes of relatives of mucopolysaccharidosis type III patients toward preconception expanded carrier screening

Preconception expanded carrier screening (ECS) aims to detect carrier couples of autosomal recessive (AR) disorders before pregnancy in order to increase reproductive autonomy of prospective parents. Genetic knowledge and knowledge gained from experience influence decision making on participation in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nijmeijer, Stephanie C. M., Conijn, Thirsa, Lakeman, Phillis, Henneman, Lidewij, Wijburg, Frits A., Haverman, Lotte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609293/ https://www.ncbi.nlm.nih.gov/pubmed/32483342 http://dx.doi.org/10.1038/s41431-020-0648-2

Ejemplares similares

Preconception expanded carrier screening: a focus group study with relatives of mucopolysaccharidosis type III patients and the general population
por: Conijn, Thirsa, et al.
Publicado: (2021)

Preconception expanded carrier screening: Impact of information presented by text or video on genetic knowledge and attitudes
por: Conijn, Thirsa, et al.
Publicado: (2020)

Preconceptional genetic carrier testing and the commercial offer directly-to-consumers
por: Borry, Pascal, et al.
Publicado: (2011)

Reducing posttraumatic stress in parents of patients with a rare inherited metabolic disorder using eye movement desensitization and reprocessing therapy: a case study
por: Conijn, Thirsa, et al.
Publicado: (2021)

Views of patients and parents of children with genetic disorders on population‐based expanded carrier screening
por: Woudstra, Anke J., et al.
Publicado: (2022)

Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening?
por: Holtkamp, Kim C A, et al.
Publicado: (2016)

Couples’ experiences with expanded carrier screening: evaluation of a university hospital screening offer
por: van Dijke, Ivy, et al.
Publicado: (2021)

Factors for successful implementation of population-based expanded carrier screening: learning from existing initiatives
por: Holtkamp, Kim C.A., et al.
Publicado: (2017)

Stakeholder perspectives on the implementation of genetic carrier screening in a changing landscape
por: Holtkamp, Kim C.A., et al.
Publicado: (2017)

Responsible implementation of expanded carrier screening
por: Henneman, Lidewij, et al.
Publicado: (2016)

Direct-to-consumer carrier screening for cystic fibrosis via a hospital website: a 6-year evaluation
por: Holtkamp, Kim C. A., et al.
Publicado: (2018)

Prediction of phenotypic severity in mucopolysaccharidosis type IIIA
por: Knottnerus, Suzan J. G., et al.
Publicado: (2017)

Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome)
por: Valstar, Marlies J, et al.
Publicado: (2011)

Attitudes of general practitioners and midwives towards ethnicity-based haemoglobinopathy-carrier screening
por: Jans, Suze MPJ, et al.
Publicado: (2012)

How will new genetic technologies, such as gene editing, change reproductive decision-making? Views of high-risk couples
por: van Dijke, Ivy, et al.
Publicado: (2020)

Experiences of a High-Risk Population with Prenatal Hemoglobinopathy Carrier Screening in a Primary Care Setting: a Qualitative Study
por: Holtkamp, Kim C. A., et al.
Publicado: (2017)

Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder
por: Wijburg, Frits A, et al.
Publicado: (2013)

Failure to shorten the diagnostic delay in two ultra-orphan diseases (mucopolysaccharidosis types I and III): potential causes and implications
por: Kuiper, Gé-Ann, et al.
Publicado: (2018)

Dynamics of reproductive genetic technologies: Perspectives of professional stakeholders
por: van Dijke, Ivy, et al.
Publicado: (2022)

The ethics of preconception expanded carrier screening in patients seeking assisted reproduction
por: de Wert, Guido, et al.
Publicado: (2021)

Preconception Expanded Carrier Screening: A Discourse Analysis of Dutch Webpages
por: Jämterud, Sofia Morberg, et al.
Publicado: (2023)

Outcomes of an International Workshop on Preconception Expanded Carrier Screening: Some Considerations for Governments
por: Molster, Caron M., et al.
Publicado: (2017)

Corrigendum to: The ethics of preconception expanded carrier screening in patients seeking assisted reproduction
por: de Wert, Guido, et al.
Publicado: (2021)

Assessment of willingness to pay for expanded carrier screening among women and couples undergoing preconception carrier screening
por: Clarke, Elizabeth V., et al.
Publicado: (2018)

Diagnostic exome-based preconception carrier testing in consanguineous couples: results from the first 100 couples in clinical practice
por: Sallevelt, Suzanne C. E. H., et al.
Publicado: (2021)

With expanded carrier screening, founder populations run the risk of being overlooked
por: Mathijssen, Inge B., et al.
Publicado: (2017)

Attitudes of Patients with Adrenoleukodystrophy towards Sex-Specific Newborn Screening
por: Yska, Hemmo A. F., et al.
Publicado: (2023)

Societal implications of expanded universal carrier screening: a scoping review
por: van den Heuvel, Lieke M., et al.
Publicado: (2022)

“A perfect society”— Swedish policymakers’ ethical and social views on preconception expanded carrier screening
por: Matar, Amal, et al.
Publicado: (2018)

Values and value conflicts in implementation and use of preconception expanded carrier screening - an expert interview study
por: Matar, Amal, et al.
Publicado: (2019)

Assessing clinical utility of preconception expanded carrier screening regarding residual risk for neurodevelopmental disorders
por: Boonsawat, Paranchai, et al.
Publicado: (2022)

Paediatric patients report lower health‐related quality of life in daily clinical practice compared to new normative PedsQL(TM) data
por: van Muilekom, Maud M., et al.
Publicado: (2021)

Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype
por: Valstar, Marlies J., et al.
Publicado: (2010)

Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry
por: D’Aco, Kristin, et al.
Publicado: (2012)

Attitudes toward Rubella and Varicella Vaccination during Preconception Care
por: Foley, Elise, et al.
Publicado: (2021)

Effectiveness of time-limited eye movement desensitization reprocessing therapy for parents of children with a rare life-limiting illness: a randomized clinical trial
por: Conijn, T., et al.
Publicado: (2022)

An algorithm to predict phenotypic severity in mucopolysaccharidosis type I in the first month of life
por: Kingma, Sandra DK, et al.
Publicado: (2013)

Ethical issues in preconception genetic carrier screening
por: Kihlbom, Ulrik
Publicado: (2016)

Preconception genetic carrier screening: use and problems
por: Wiwanitkit, Viroj
Publicado: (2017)

Expanding preconception carrier screening for the Jewish population using high throughput microfluidics technology and next generation sequencing
por: Gal, Moran, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e01mnqfe3li3u916v465hpl5q0